MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

MDT

89.67

-0.33%↓

VEEV

282.32

+2.35%↑

A

120.08

-2.61%↓

WBA

11.51

0%↓

HQY

97.34

+3.06%↑

Search

IQVIA Holdings Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

160.09 -1.58

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

159.05

Max

162.66

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-188M

249M

Pardavimai

-129M

3.8B

P/E

Sektoriaus vid.

22.407

39.564

Pelnas, tenkantis vienai akcijai

2.7

Pelno marža

6.503

Darbuotojai

89,000

EBITDA

-268M

753M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+8.91% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-07-22

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-7.2B

28B

Ankstesnė atidarymo kaina

161.67

Ankstesnė uždarymo kaina

160.09

Naujienos nuotaikos

By Acuity

50%

50%

133 / 376 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

IQVIA Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-11 22:19; UTC

Įsigijimai, susijungimai, perėmimai

FCC Approves U.S. Cellular Sale to T-Mobile

2025-07-11 17:28; UTC

Pagrindinės rinkos jėgos

SharpLink Gaming Gains on Ethereum Purchase

2025-07-11 16:57; UTC

Uždarbis

BASF Cuts Outlook on Global Economy Uncertainty

2025-07-13 23:54; UTC

Rinkos pokalbiai

Oil Edges Higher Amid Supply Disruption Worries -- Market Talk

2025-07-13 23:49; UTC

Rinkos pokalbiai

Nikkei May Fall Amid U.S. Tariff Uncertainty -- Market Talk

2025-07-13 23:49; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-13 23:40; UTC

Rinkos pokalbiai

Market Talk Roundup: Latest on U.S. Politics

2025-07-13 23:40; UTC

Rinkos pokalbiai

Gold Advances Amid Rising Trade Tensions -- Market Talk

2025-07-13 23:39; UTC

Rinkos pokalbiai

China's Growth Momentum Likely Slowed in 2Q -- Market Talk

2025-07-13 23:16; UTC

Uždarbis

China Shenhua Energy 1H 2024 Net Was CNY32.8B>1088.HK

2025-07-13 23:16; UTC

Uždarbis

China Shenhua Energy: Drop in Coal Prices Weighed on Results >1088.HK

2025-07-13 23:16; UTC

Uždarbis

China Shenhua Energy Sees 1H Net CNY25.6B-Net CNY27.6B >1088.HK

2025-07-13 23:13; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-07-13 23:13; UTC

Rinkos pokalbiai

Ryman Healthcare Could Be Turning a Corner -- Market Talk

2025-07-13 11:00; UTC

Įsigijimai, susijungimai, perėmimai

The Private-Equity Maneuver Allowing More Investors to Cash Out -- WSJ

2025-07-12 02:24; UTC

Įsigijimai, susijungimai, perėmimai

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- Update

2025-07-12 02:05; UTC

Įsigijimai, susijungimai, perėmimai

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- WSJ

2025-07-12 02:05; UTC

Įsigijimai, susijungimai, perėmimai

Google to Hire Windsurf CEO and Other Employees, Company Says -- WSJ

2025-07-12 02:05; UTC

Įsigijimai, susijungimai, perėmimai

Google to Pay About $2.4 Billion in Deal to License Tech of AI Coding Startup, Sources Say -- WSJ

2025-07-11 21:45; UTC

Rinkos pokalbiai

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

2025-07-11 19:46; UTC

Įsigijimai, susijungimai, perėmimai

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

2025-07-11 19:45; UTC

Rinkos pokalbiai

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

2025-07-11 19:05; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

2025-07-11 18:18; UTC

Rinkos pokalbiai

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

2025-07-11 17:35; UTC

Rinkos pokalbiai

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

2025-07-11 17:26; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

2025-07-11 16:53; UTC

Rinkos pokalbiai

Crude Futures Add to Early Gains -- Market Talk

2025-07-11 16:42; UTC

Uždarbis

BASF Cuts Outlook on Global Economic Uncertainty

2025-07-11 16:08; UTC

Rinkos pokalbiai

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

2025-07-11 16:05; UTC

Uždarbis

BASF Will Publish Half-Year Results on July 30

Akcijų palyginimas

Kainos pokytis

IQVIA Holdings Inc Prognozė

Kainos tikslas

By TipRanks

8.91% į viršų

12 mėnesių prognozė

Vidutinis 177.31 USD  8.91%

Aukščiausias 211 USD

Žemiausias 159 USD

Remiantis 15 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines IQVIA Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

15 ratings

11

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

150.68 / 153.45Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Bullish Evidence

Vidutinės trukmės periodas

Neutral Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

133 / 376 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.